New Markers of Aortic Stenosis Define Asymptomatic Patients

Asymptomatic aortic stenosis has been keeping us in tense stillness. However, there are new markers capable of identifying patients that might benefit from earlier intervention. In this regard, cardiovascular magnetic resonance (CMR) has been gaining its well-deserved place in cardiology and now more specifically in aortic stenosis. 

Nuevos marcadores de daño en estenosis aórtica que definen pacientes asintomáticos

This study sought to validate CMR markers of prognostic value to aortic stenosis and its thresholds to predict mortality.   

The study prospectively included 799 aortic stenosis patients (n=440 in the derivation cohort and n=359 in the validation cohort) from 13 international centers followed up for nearly 4 years. 

CMR was done shortly before surgical or transcatheter aortic valve replacement (AVR). A forest model was used with 29 variables (13 CMR) capable of predicting mortality and post procedure events. 

There were 52 deaths in the derivation cohort and 51 deaths in the validation cohort. The 4 CMR markers with most predictive power were extracellular volume fraction, late gadolinium enhancement, indexed left ventricular end-diastolic volume, and right ventricular ejection fraction.  

Mortality increased significantly both in the global cohort and among asymptomatic patients when extracellular volume fraction exceeded 27%. 2% of late gadolinium enhancement showed persistent high risk. 


Read also: Anticoagulation with Heparin in Non-Critical COVID-19.


As regards indexed left ventricular end-diastolic volume, increased mortality was also observed at both extremes. High (>80 ml/m2) and low volumes (<55 ml/m2) were mortality predictors.  

There was also increased mortality with high (>80%) and low (≤50%) right ventricular ejection fraction (>80% y <50%).

Predictability improved even further when these 4 markers were combined with clinical factors 


Read also: Heparin Anticoagulation in Critically Ill COVID-19 Patients: Results that Differ from the Rest.


The prognostic thresholds and risk stratification by CMR variables were reproduced in the validation cohort. 

Conclusion

Myocardial fibrosis and biventricular remodeling are the best prognostic factors in patients with aortic stenosis. We should highlight its non-linear association with mortality. 

CMR has the potential to optimize decision making in treating patients with aortic stenosis. 

Original Title: Markers of Myocardial Damage Predict Mortality in Patients With Aortic Stenosis.

Reference: Soongu Kwak et al. J Am Coll Cardiol. 2021 Aug 10;78(6):545-558. doi: 10.1016/j.jacc.2021.05.047.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Percutaneous Mechanical Aspiration versus Surgical Treatment of Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis (TVIE) accounts for approximately 5% to 10% of all cases of infective endocarditis. Surgical treatment remains the standard therapy in...

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...